$31.490
+0.009 (+0.03%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CPRX por análisis de gráficos similares
Alphio's CPRX stock price prediction model matches the current Catalyst Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $31.56 (+0.21%). The 1-week path is $32.28 (+2.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Catalyst Pharmaceuticals Inc?
CPRX is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is essentially pinned near the announced acquisition price of $31.50 per share, so upside is limited from current levels around $31.44. Since the deal already appears to be the main driver, this is more of a merger-arbitrage situation than a long-term growth investment. Given the lack of a clear premium and the absence of strong proprietary buy signals today, I would not recommend chasing it as a new long-term purchase.
CPRX cerró en $31.49 el Tuesday, tras subir +0.03%
Catalyst Pharmaceuticals Inc (CPRX) last closed at $31.49, gaining +0.03%. These facts feed the 1-day and 1-week CPRX price prediction above.
Consenso de analistas
Catalyst Pharmaceuticals Inc (CPRX): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Catalyst Pharmaceuticals Inc (CPRX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CPRX, ordenadas por similitud.
Análisis de estacionalidad de CPRX
Historically the probability of a positive September return for CPRX is 48.78%. December offers the highest probability of a positive month at 100.00%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CPRX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $21.99 | $28.56 | $37.23 | -9.29% |
| Oct 2026 | $30.56 | $35.83 | $43.47 | +13.78% |
| Nov 2026 | $35.16 | $35.83 | $41.51 | +13.78% |
| Dec 2026 | $28.80 | $29.88 | $30.18 | -5.10% |
En 2026, se proyecta que Catalyst Pharmaceuticals Inc (CPRX) oscile entre $21.99 y $43.47.
Previsión mensual de Catalyst Pharmaceuticals Inc para 2026
En Sep de 2026, se proyecta que Catalyst Pharmaceuticals Inc promedie $28.56, con un mínimo de $21.99 y un máximo de $37.23.
En Oct de 2026, se proyecta que Catalyst Pharmaceuticals Inc promedie $35.83, con un mínimo de $30.56 y un máximo de $43.47.
En Nov de 2026, se proyecta que Catalyst Pharmaceuticals Inc promedie $35.83, con un mínimo de $35.16 y un máximo de $41.51.
En Dec de 2026, se proyecta que Catalyst Pharmaceuticals Inc promedie $29.88, con un mínimo de $28.80 y un máximo de $30.18.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.